Applied DNA Sciences, Inc.
APDN · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $1,932,843 | $11,865,944 | $7,600,126 | $27,961,973 |
| - Cash | $6,431 | $7,152 | $15,215 | $6,555 |
| + Debt | $739 | $1,238 | $0 | $0 |
| Enterprise Value | $1,927,151 | $11,860,030 | $7,584,910 | $27,955,418 |
| Revenue | $3,431 | $13,367 | $18,169 | $9,028 |
| % Growth | -74.3% | -26.4% | 101.3% | – |
| Gross Profit | $1,017 | $5,533 | $5,054 | $4,928 |
| % Margin | 29.6% | 41.4% | 27.8% | 54.6% |
| EBITDA | -$13,328 | -$9,591 | -$12,679 | -$11,682 |
| % Margin | -388.4% | -71.7% | -69.8% | -129.4% |
| Net Income | -$6,993 | -$9,947 | -$8,378 | -$16,029 |
| % Margin | -203.8% | -74.4% | -46.1% | -177.6% |
| EPS Diluted | -1.82 | -15.21 | -18.68 | -46.35 |
| % Growth | 88% | 18.6% | 59.7% | – |
| Operating Cash Flow | -$13,711 | -$6,218 | -$8,977 | -$13,388 |
| Capital Expenditures | -$408 | -$78 | -$490 | -$2,549 |
| Free Cash Flow | -$14,119 | -$6,296 | -$9,466 | -$15,937 |